Brokerages Set Urogen Pharma (NASDAQ:URGN) PT at $32.86
Urogen Pharma (NASDAQ:URGN – Get Free Report) has earned a consensus recommendation of “Buy” from the eight brokerages that are currently covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a hold rating, six have assigned a buy rating and one has issued a strong buy rating on the company. The […]
Urogen Pharma (NASDAQ:URGN – Get Free Report) has earned a consensus recommendation of “Buy” from the eight brokerages that are currently covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a hold rating, six have assigned a buy rating and one has issued a strong buy rating on the company. The […]
